[e-drug] Information about Romania?

E-DRUG: Information about Romania?
-------------------------------------------
[To respond DO NOT CLICK REPLY. Please respond directly to Aizhan <imasheva@gmail.com> ]

Dear E-druggers,

I am collecting information about Romanian pharmaceutical market and I
would appreciate your help if you have some recent data on
pharmaceutical market, policy documents, overall performance of
pharmaceutical sector, drug expenditure. Some potential sources include
such documents as:
    * MOH
    * Drug regulatory agency
    * WHO
    * Public health institute or local academic think tanks
    * Association of research-based industry (with access to IMS data
      and possibly other consultant reports)
    * Association of national drug industry
    * Pharmacists association

It would excellent to have these documents in English but if not
available some selective translations are possible based on the
relevance and actuality.

Feel free to suggest other additional sources of information and we are
particularly interested in basic data that describe the pharmaceutical
sector:

    * Total pharmaceutical market (retail or wholesale value) for last
      three years (2004-2006)
    * Total public spending on drugs for last three years (health
      insurance, direct programs if they exist, hospital drug spending
      if known)
    * Total private out-of pocket spending for drugs in last three years
    * Top 20 drugs by value (paid by health insurance) for the last
      three years
    * Positive drug list(s), reimbursement list from health insurance
      (may be on the web but I didn't find it) - no translation needed!
    * Number of national manufacturers, pharmacies (public/private) and
      wholesalers
    * Official price lists for drugs and a description of the price
      setting mechanism if available
    * Similarly, a description of the mechanism by which new drugs are
      included into the reimbursement list and how the reimbursement
      rate is set
    * Information on patient co-payments and exemptions from such
      co-payments

Thank you,
Aizhan Imasheva
World Bank Consultant
Aizhan Imasheva <imasheva@gmail.com>